K. J. Looker, A. S. Magaret, K. M. Turner, P. Vickerman, S. L. Gottlieb et al., Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012, PLoS One, vol.10, p.114989, 2015.

R. S. Mcclelland, C. C. Wang, and J. Overbaugh, Association between cervical shedding of herpes simplex virus and HIV-1, AIDS, vol.16, pp.2425-2455, 2002.

C. Tanton, H. A. Weiss, L. Goff, and J. , Correlates of HIV-1 genital shedding in Tanzanian women, PLoS One, vol.6, p.17480, 2011.

V. H. Ferreira, A. Nazli, K. L. Mossman, and C. Kaushic, Proinflammatory cytokines and chemokines -but not interferon-beta -produced in response to HSV-2 in primary human genital epithelial cells are associated with viral replication and the presence of the virion host shutoff protein, Am J Reprod Immunol, vol.70, pp.199-212, 2013.

C. Johnston, J. Zhu, and L. Jing, Virologic and immunologic evidence of multifocal genital herpes simplex virus 2 infection, J Virol, vol.88, pp.4921-4952, 2014.

C. M. Posavad, D. M. Koelle, M. F. Shaughnessy, and L. Corey, Severe genital herpes infections in HIV-infected individuals with impaired herpes simplex virus-specific CD8+ cytotoxic T lymphocyte responses, Proc Natl Acad Sci U S A, vol.94, pp.10289-94, 1997.

N. Nagot, A. Ouedraogo, and I. Konate, Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels, J Infect Dis, vol.198, pp.241-250, 2008.

M. Augenbraun, J. Feldman, and K. Chirgwin, Increased genital shedding of herpes simplex virus type 2 in HIV-seropositive women, Ann Intern Med, vol.123, pp.845-852, 1995.

E. Tronstein, C. Johnston, and M. L. Huang, Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection, JAMA, vol.305, pp.1441-1450, 2011.

A. Wald, J. Zeh, S. Selke, R. L. Ashley, and L. Corey, Virologic characteristics of subclinical and symptomatic genital herpes infections, N Engl J Med, vol.333, pp.770-775, 1995.

K. E. Mark, W. A. Magaret, and A. S. , Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults, J Infect Dis, vol.198, pp.1141-1150, 2008.

S. M. Graham, L. Masese, and R. Gitau, Increased risk of genital ulcer disease in women during the first month after initiating antiretroviral therapy, J Acquir Immune Defic Syndr, vol.52, pp.600-603, 2009.

A. A. Tobian, M. K. Grabowski, and D. Serwadda, Reactivation of herpes simplex virus type 2 after initiation of antiretroviral therapy, J Infect Dis, vol.208, pp.839-885, 2013.

N. Nagot, A. Ouangre, and A. Ouedraogo, Spectrum of commercial sex activity in Burkina Faso: classification model and risk of exposure to HIV, J Acquir Immune Defic Syndr, vol.29, pp.517-538, 2002.

A. J. Low, T. Clayton, and I. Konate, Genital warts and infection with human immunodeficiency virus in high-risk women in Burkina Faso: a longitudinal study, BMC Infect Dis, vol.11, p.20, 2011.

C. Huet, A. Ouedraogo, and I. Konate, Long term virological, immunological and mortality outcomes in a cohort of HIV-infected female sex workers treated with highly active antiretroviral therapy in Africa, BMC Public Health, vol.11, p.700, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00631427

, Scaling up antiretroviral therapy in resource-limited settings guidelines for a public health approach. Geneva: World Health Organization, 2002.

N. Nagot, A. Ouedraogo, and V. Foulongne, Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus, N Engl J Med, vol.356, pp.790-799, 2007.

A. Ouedraogo, N. Nagot, and L. Vergne, Impact of suppressive herpes therapy on genital HIV-1 RNA among women taking antiretroviral therapy: a randomized controlled trial, AIDS, vol.20, pp.2305-2318, 2006.

N. Nagot, V. Foulongne, and P. Becquart, Longitudinal assessment of HIV-1 and HSV-2 shedding in the genital tract of West African women, J Acquir Immune Defic Syndr, vol.39, pp.632-636, 2005.

F. Rouet, V. Foulongne, and J. Viljoen, Comparison of the Generic HIV Viral Load assay with the Amplicor HIV-1 monitor v1.5 and Nuclisens HIV-1 EasyQ v1.2 techniques for plasma HIV-1 RNA quantitation of non-B subtypes: the Kesho Bora preparatory study, J Virol Methods, vol.163, pp.253-260, 2010.

J. Burrows, A. Nitsche, B. Bayly, E. Walker, G. Higgins et al., Detection and subtyping of Herpes simplex virus in clinical samples by LightCycler PCR, enzyme immunoassay and cell culture, BMC Microbiol, vol.2, p.12, 2002.

A. J. Low, I. Konate, and N. Nagot, Neisseria gonorrhoeae and Chlamydia trachomatis infection in HIV-1-infected women taking antiretroviral therapy: a prospective cohort study from Burkina Faso, Sex Transm Infect, vol.90, pp.100-103, 2014.
URL : https://hal.archives-ouvertes.fr/hal-02095253

N. Chomont, G. Gresenguet, and M. Levy, Detection of Y chromosome DNA as evidence of semen in cervicovaginal secretions of sexually active women, Clin Diagn Lab Immunol, vol.8, pp.955-963, 2001.

, Panel on Antiretroviral Guidelines for Adults and Adolescents, Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents, 2015.

B. Aumakhan, S. J. Gange, and C. Beyrer, Quantitative and qualitative correlates of cervicovaginal herpes simplex virus type 2 shedding among HIV-infected women in the Women's Interagency HIV Study, Int J STD AIDS, vol.22, pp.273-280, 2011.

M. Ramaswamy, A. Waters, and C. Smith, Reconstitution of herpes simplex virusspecific T cell immunity in HIV-infected patients receiving highly active antiretroviral therapy, J Infect Dis, vol.195, pp.410-415, 2007.

E. K. Bagdades, D. Pillay, S. B. Squire, O. Neil, C. Johnson et al., Relationship between herpes simplex virus ulceration and CD4+ cell counts in patients with HIV infection, AIDS, vol.6, pp.1317-1337, 1992.

P. Van-de-perre, M. Segondy, and V. Foulongne, Herpes simplex virus and HIV-1: deciphering viral synergy, Lancet Infect Dis, vol.8, pp.490-497, 2008.

A. Rebbapragada, C. Wachihi, and C. Pettengell, Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract, AIDS, vol.21, pp.589-98, 2007.

P. M. Sheth, S. Sunderji, and L. Y. Shin, Coinfection with herpes simplex virus type 2 is associated with reduced HIV-specific T cell responses and systemic immune activation, J Infect Dis, vol.197, pp.1394-401, 2008.

A. J. Low, I. Konate, and N. Nagot, Cervicovaginal HIV-1 shedding in women taking antiretroviral therapy in Burkina Faso: a longitudinal study, J Acquir Immune Defic Syndr, vol.65, pp.237-282, 2014.

C. M. Posavad, A. Wald, and S. Kuntz, Frequent reactivation of herpes simplex virus among HIV-1-infected patients treated with highly active antiretroviral therapy, J Infect Dis, vol.190, pp.693-699, 2004.

D. H. Tan, J. M. Raboud, R. Kaul, and S. L. Walmsley, Antiretroviral therapy is not associated with reduced herpes simplex virus shedding in HIV coinfected adults: an observational cohort study, BMJ Open, vol.4, p.4210, 2014.

P. Mayaud, J. Legoff, and H. A. Weiss, Impact of acyclovir on genital and plasma HIV-1 RNA, genital herpes simplex virus type 2 DNA, and ulcer healing among HIV-1-infected African women with herpes ulcers: a randomized placebo-controlled trial, J Infect Dis, vol.200, pp.216-242, 2009.

J. Legoff, H. A. Weiss, and G. Gresenguet, Cervicovaginal HIV-1 and herpes simplex virus type 2 shedding during genital ulcer disease episodes, AIDS, vol.21, pp.1569-78, 2007.

B. Aumakhan, A. Hardick, and T. C. Quinn, Genital herpes evaluation by quantitative TaqMan PCR: correlating single detection and quantity of HSV-2 DNA in cervicovaginal lavage fluids with cross-sectional and longitudinal clinical data, Virol J, vol.7, p.328, 2010.